Medical oversight support for oncology clinical trials
Challenge:
A listed biotech company conducting Phase III clinical trials in an oncology indication needed Chief Medical Officer support for multiple clinical activities in Europe and the United States.
Solution:
We provided medical oversight of three ongoing clinical trials, in particular, providing medical oversight for a Phase I trial and preparing for:
- marketing application
- data and safety measurement board (DSMB) review of an ongoing Phase IIb clinical trial
- launch of a Phase II clinical study in pancreatic cancer
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Product Development
Gene therapy preclinical, CMC, and regulatory strategy
Challenge: An early-stage biotechnology startup company reached out to Alacrita for critical support of its two lead AAV-delivered gene therapy programs. As a virtual company, the...
Product Development
Interim chief medical officer for antiviral drug company
Challenge A European company developing novel antiviral drugs urgently needed an experienced pharmaceutical physician to work as an interim CMO, as the predecessor was about to...
Product Development
Preclinical development support for a gene therapy
Challenge: A biotech company developing novel gene therapy approaches for in vivo cell trans-differentiation required an AAV gene therapy expert to serve on a scientific advisory...
Product Development
Primary market research and patient segmentation mapping in myelofibrosis
Challenge: A venture-backed US biotech company was developing a preclinical biologic for haematological indications and wished to quantify the commercial opportunity for the...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.